MAPT and Alzheimer disease: Detailed studies indicated that the synthesized nanostructures could travel across the BBB, stimulate amyloid‐β and tau degradation, facilitate microgliosis, and restore memory capabilities in AD mouse models. Thus, the nanoparticles under investigation exhibit promising attributes that render them viable candidates for safe and biocompatible therapeutic interventions.